Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedSkin Solutions Dr. Suwelack is a private German regenerative medicine and skin health company focused on collagen-based medical devices, advanced wound care, dermal matrices, and premium private-label skin care. The company develops, manufactures, and commercializes tissue-regeneration products for medical care and aesthetic applications, with flagship MedCare products including MatriDerm dermal matrix and ProHeal collagen wound dressing. Its technology base centers on proprietary biomaterial-processing methods, especially the Advanced CryoSafe platform, designed to preserve native biomaterial structure and function. In addition to branded MedCare products, the company provides contract development and manufacturing services for collagen-based medical devices and manufactures clinically supported skin care products for professional and consumer brands. The business operates internationally from Germany with offices and subsidiaries in Europe, Asia, and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedSkin Solutions Dr. Suwelack.